CS
OLMA icon

Credit Suisse’s Olema Pharmaceuticals OLMA Stock Holding History

Credit Suisse’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$537K Buy
47,446
+3,850
+9% +$49.7K ﹤0.01% 2608
2023
Q4 		$612K Buy
+43,596
New +$586K ﹤0.01% 2626
2022
Q3 		– Sell
-14
Closed – – 4203
2022
Q2 		$0 Buy
+14
New +$44 ﹤0.01% 4192

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Credit Suisse's OLMA Position: Q1 2024 in Review

Credit Suisse increased its Olema Pharmaceuticals (OLMA) stake by 8.8% in Q1 2024, buying an estimated $49.7K and bringing the position to 47,446 shares worth $537K. The position accounts for ﹤0.01% of the portfolio, ranked #2608.

Credit Suisse first reported a position in OLMA in Q2 2022 and has held it in 3 quarters since. The position peaked at $612K in Q4 2023. 126 funds tracked by Wall St. Rank hold OLMA as of Q1 2024.

  • Credit Suisse held 47,446 shares of Olema Pharmaceuticals worth $537K as of Q1 2024.
  • Credit Suisse bought 3,850 Olema Pharmaceuticals shares in Q1 2024, an estimated $49.7K.
  • Olema Pharmaceuticals made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2608 holding.
  • Credit Suisse first reported a position in Olema Pharmaceuticals in Q2 2022 and has held it in 3 quarters since.
  • Credit Suisse's Olema Pharmaceuticals position peaked at $612K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.